Tag: muscle strength

Parent Project Muscular Dystrophy Announces Children’s Hospital of Philadelphia as Certified Duchenne Care Center, Recipient of Inaugural Clinical Research Designation

WASHINGTON, June 12, 2025 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is...

Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics

Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. New agreemen

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

June 11, 2025, 12:01 AM CET

Avidity Biosciences Announces Positive Topline Phase 1/2 FORTITUDE™ Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD Participants

-- Unprecedented data from FORTITUDE™ dose escalation cohorts for del-brax treated participants, compared to placebo, demonstrate improvement in function, strength and PROs as well...

- A word from our sponsors -

HomeTagsMuscle strength

CDP Announces Transformative Investment to Accelerate Environmental Transparency Worldwide

Vietnam-aligned OceanLotus pivots to spy on domestic targets as it takes a more selective approach abroad, ESET Research finds

IUX Publishes Analysis of ETF Risk Factors During Periods of Market Volatility

Tag: muscle strength

Parent Project Muscular Dystrophy Announces Children’s Hospital of Philadelphia as Certified Duchenne Care Center, Recipient of Inaugural Clinical Research Designation

Wandercraft announces Series D Round, bringing $75M in total funding secured for global acceleration of AI-powered robotics

argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease

Avidity Biosciences Announces Positive Topline Phase 1/2 FORTITUDE™ Data Demonstrating Consistent Improvement Across Multiple Functional Measures Compared to Placebo in Del-Brax Treated FSHD Participants

Explore

Press Releases

News & Opinion

Living

Others

Follow us